Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Enrolling by invitation × Cytarabine × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2/3 1

Status

Completed 9 Unknown 6 Recruiting 5 Active not recruiting 4 Not yet recruiting 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasm, Residual 1 Leukemia, Myeloid, Acute 1

Interventions

venetoclax 1 futibatinib 1 Tacrolimus 1 Fulvestrant 1 Cytarabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07537257 2026-04-17

VEN+IDAC vs IDAC in AML

Guangdong Second Provincial General Hospital

Phase 2/3 Enrolling by invitation

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡